Trial Profile
The Systemic And Local Immune Response To Intranasal Influenza Vaccination
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 08 Dec 2023
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine live (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- 05 Dec 2023 Planned End Date changed from 31 Dec 2022 to 31 Dec 2030.
- 05 Dec 2023 Planned primary completion date changed from 31 Dec 2022 to 31 Dec 2025.
- 01 Aug 2021 Planned End Date changed from 1 Dec 2022 to 31 Dec 2022.